Skip to main content
. Author manuscript; available in PMC: 2009 Dec 8.
Published in final edited form as: Mol Cancer Ther. 2009 Jan;8(1):232–239. doi: 10.1158/1535-7163.MCT-08-0862

Figure 5.

Figure 5

In vivo fluorescence imaging with orthotopic (breast) tumor bearing mice. The images were obtained two days after the trastuzumab-Cy5.5 or Alexa680 conjugates injection. The target tumor (3T3/HER2+) was specifically imaged with low background with Tra-Alexa680(SQ).